A fully-funded PhD opportunity is available in the Cancer Biology and Therapeutics lab at the National Horizons Centre, Teesside University, as part of the BBSRC Yorkshire Bioscience Doctoral Training Partnership. The project focuses on understanding how the loss of DNA damage response modulates immune signalling to drive immune cell localization and function, using ovarian cancer 3D models. This research aims to advance knowledge in cancer biology and immunology, with potential implications for cancer therapeutics.

The PhD is a collaborative effort between Teesside University (supervisors: Sweta Sharma Saha and Professor Vikki Rand) and the University of Sheffield (Helen E Bryant), offering the opportunity to train and work with partners in academia, clinical settings, and industry. The successful candidate will join a dynamic research environment at the National Horizons Centre, gaining experience in cutting-edge cancer research and 3D modeling techniques.

The studentship is fully funded, covering tuition fees and providing a stipend (exact amount not specified). Applicants should have a strong interest in cancer research and hold a relevant undergraduate or master's degree in biology, biomedical sciences, or a related field. Experience or interest in cancer biology, immunology, or laboratory research is desirable.

To apply, submit your expression of interest and application using the online form provided in the link. For informal enquiries, contact Sweta Sharma Saha at [email protected]. The application deadline is January 7, 2026.